321 related articles for article (PubMed ID: 18265983)
1. A positive antinuclear antibody test predicts for a poor response to initial steroid therapy in adults with idiopathic thrombocytopenic purpura.
Abbasi SY; Milhem M; Zaru L
Ann Hematol; 2008 Jun; 87(6):459-62. PubMed ID: 18265983
[TBL] [Abstract][Full Text] [Related]
2. Chronic idiopathic thrombocytopenic purpura in adult Chinese patients: a retrospective single-centered analysis of 1791 cases.
Li HQ; Zhang L; Zhao H; Ji LX; Yang RC
Chin Med J (Engl); 2005 Jan; 118(1):34-7. PubMed ID: 15642223
[TBL] [Abstract][Full Text] [Related]
3. Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.
Pamuk GE; Pamuk ON; Başlar Z; Ongören S; Soysal T; Ferhanoğlu B; Aydin Y; Ulkü B; Aktuğlu G; Akman N
Ann Hematol; 2002 Aug; 81(8):436-40. PubMed ID: 12224000
[TBL] [Abstract][Full Text] [Related]
4. [Clinical significance of antinuclear antibody in patients with idiopathic thrombocytopenic purpura].
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Rinsho Ketsueki; 1992 Sep; 33(9):1178-82. PubMed ID: 1433939
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of elevated antithyroid antibodies and antinuclear antibodies in children with immune thrombocytopenic purpura.
Pratt EL; Tarantino MD; Wagner D; Hirsch Pescovitz O; Bowyer S; Shapiro AD
Am J Hematol; 2005 Jul; 79(3):175-9. PubMed ID: 15981229
[TBL] [Abstract][Full Text] [Related]
6. High-titer antinuclear antibodies, anti-SSA/Ro antibodies and anti-nuclear RNP antibodies in patients with idiopathic thrombocytopenic purpura.
Kurata Y; Miyagawa S; Kosugi S; Kashiwagi H; Honda S; Mizutani H; Tomiyama Y; Kanayama Y; Matsuzawa Y
Thromb Haemost; 1994 Feb; 71(2):184-7. PubMed ID: 8191396
[TBL] [Abstract][Full Text] [Related]
7. The effect of platelet autoantibodies on the course of the disease and clinical response of patients with idiopathic thrombocytopenic purpura.
Sikorska A; Konopka L; Maślanka K
Int J Lab Hematol; 2008 Feb; 30(1):58-64. PubMed ID: 18190469
[TBL] [Abstract][Full Text] [Related]
8. Initial treatment of immune thrombocytopenic purpura with high-dose dexamethasone.
Cheng Y; Wong RS; Soo YO; Chui CH; Lau FY; Chan NP; Wong WS; Cheng G
N Engl J Med; 2003 Aug; 349(9):831-6. PubMed ID: 12944568
[TBL] [Abstract][Full Text] [Related]
9. Screening for autoimmune markers is unnecessary during follow-up of adults with autoimmune thrombocytopenic purpura and no autoimmune markers at onset.
Vantelon JM; Godeau B; André C; Bierling P
Thromb Haemost; 2000 Jan; 83(1):42-5. PubMed ID: 10669152
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura.
Julia A; Kovaleva L; Loria S; Alberca I; Hernandez F; Sandoval V; Sierra J; Vidaller A; Ayguasanosa J; Carretero M
Transfus Med; 2009 Oct; 19(5):260-8. PubMed ID: 19747289
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of the antinuclear antibody test in selected children with idiopathic thrombocytopenic purpura.
Zimmerman SA; Ware RE
J Pediatr Hematol Oncol; 1997; 19(4):297-303. PubMed ID: 9256827
[TBL] [Abstract][Full Text] [Related]
12. Current management of adult idiopathic thrombocytopenic purpura in practice: a cohort study of 201 patients from a single center.
Zimmer J; Andrès E; Noel E; Koumarianou A; Blicklé JF; Maloisel F
Clin Lab Haematol; 2004 Apr; 26(2):137-42. PubMed ID: 15053808
[TBL] [Abstract][Full Text] [Related]
13. The initial manifestations and final diagnosis of patients with high and low titers of antinuclear antibodies after 6 months of follow-up.
Wang KY; Yang YH; Chuang YH; Chan PJ; Yu HH; Lee JH; Wang LC; Chiang BL
J Microbiol Immunol Infect; 2011 Jun; 44(3):222-8. PubMed ID: 21524618
[TBL] [Abstract][Full Text] [Related]
14. Platelet response to Helicobacter pylori eradication therapy in adult chronic idiopathic thrombocytopenic purpura seems to be related to the presence of anticytotoxin-associated gene A antibodies.
Scandellari R; Allemand E; Vettore S; Plebani M; Randi ML; Fabris F
Blood Coagul Fibrinolysis; 2009 Mar; 20(2):108-13. PubMed ID: 19786938
[TBL] [Abstract][Full Text] [Related]
15. Role of splenectomy in chronic idiopathic thrombocytopenic purpura.
Srinivasan S; Sabapathy K; Bharadwaj TP; Sethuraman S
J Assoc Physicians India; 2003 Feb; 51():159-62. PubMed ID: 12725258
[TBL] [Abstract][Full Text] [Related]
16. Prospective screening of 205 patients with ITP, including diagnosis, serological markers, and the relationship between platelet counts, endogenous thrombopoietin, and circulating antithrombopoietin antibodies.
Aledort LM; Hayward CP; Chen MG; Nichol JL; Bussel J;
Am J Hematol; 2004 Jul; 76(3):205-13. PubMed ID: 15224353
[TBL] [Abstract][Full Text] [Related]
17. Hydroxychloroquine is a good second-line treatment for adults with immune thrombocytopenia and positive antinuclear antibodies.
Khellaf M; Chabrol A; Mahevas M; Roudot-Thoraval F; Limal N; Languille L; Bierling P; Michel M; Godeau B
Am J Hematol; 2014 Feb; 89(2):194-8. PubMed ID: 24254965
[TBL] [Abstract][Full Text] [Related]
18. [Nine-year's follow up on the appearance of autoantibodies in a child with idiopathic thrombocytopenic purpura subsequently developing lupus with central nervous system manifestations].
Kagitani M; Makino S; Kinjo Y; Hirano S; Tabushi Y; Sasaki M; Takeuchi T; Hanafusa T; Murata T
Ryumachi; 2002 Jun; 42(3):591-6. PubMed ID: 12166113
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for future development of systemic lupus erythematosus in children with idiopathic thrombocytopenic purpura.
Hazzan R; Mukamel M; Yacobovich J; Yaniv I; Tamary H
Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):657-9. PubMed ID: 16933242
[TBL] [Abstract][Full Text] [Related]
20. Adult primary and secondary immune thrombocytopenic purpura: a comparative analysis of characteristics and clinical course.
Ayesh MH; Alawneh K; Khassawneh B; Khader Y; Kasasbeh A
Clin Appl Thromb Hemost; 2013 Jun; 19(3):327-30. PubMed ID: 22275396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]